Consider the followingstatements.
1.Innovate in India (i3) program offers young entrepreneurs an avenue to engage with the best practices in the domestic financial and banking industry.
2.National Biopharma Mission will concentrate, inter alia, on development of medical devices and biotherapeuticstoupgradeIndia’sproductdevelopmentcapabilitiestogloballycompetitivelevels.
Which of the above is/arecorrect?
Both 1 and 2
Incorrect AnswerExplanation:
Statement 1: i3 is aflagshipprogram of the Government of Indiaincollaboration with World Bank. It is committed to make India a hub for design and development of novel, affordable and effective biopharmaceuticalproductsandsolutions by engaging withentrepreneurs.
It will strive to increase India’s global biopharmaceutical market share from current 2.8% to 5% and generate additional business opportunity of $16 billion.
Statement 2 (S2): It will bring together expertise from national and international corridors to provide strategic direction and guidance to move promising solutions through the product development value chain.
The mission will be implemented by Biotechnology Industry Research Assistance Council (BIRAC), a PSU of Department ofBiotechnology.
Besides, it will also work on establishment of shared infrastructure and facilities and at the same timecreatingand enhancingtechnologytransfercapabilitiesinpublicandprivatesector.
![]()
By: kamaljeet kaur